Ceva Santé Animale
Private Equity Round in 2025
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.
Ourofino
Secondary Market in 2022
Ourofino is a animal health company, serving two segments: livestock/production animals and pet/companion animals.
Hendrix Genetics
Private Equity Round in 2021
Hendrix Genetics, headquartered in Boxmeer, is a prominent company specializing in animal breeding, focusing on a diverse range of species including laying hens, turkeys, traditional poultry, pigs, salmon, trout, and shrimp. The company aims to provide sustainable genetic solutions to address the increasing global demand for food, while also tackling contemporary and future challenges in the animal protein sector. With a robust portfolio of leading product brands, Hendrix Genetics offers expertise and services to producers across more than 100 countries, operating through activities and joint ventures in 24 countries and employing over 2,500 people worldwide.
Ceva Santé Animale
Venture Round in 2020
Ceva Santé Animale S.A. specializes in the research, development, production, and marketing of veterinary pharmaceuticals and vaccines for both companion and farm animals. The company provides a diverse range of products, including treatments for behavior, cardiology, nephrology, dermatology, locomotion, parasitology, and reproduction management for companion animals. For farm animals, Ceva offers anti-infective products, vaccines, and reproductive management solutions for cattle, sheep, goats, swine, and poultry. Additionally, the company has developed tools such as the Ceva Lung Program, a mobile application that helps manage lung health in livestock. Established in 1988 and headquartered in Libourne, France, Ceva operates pharmaceutical and research facilities in various countries, including Canada, Brazil, Italy, Hungary, the United States, Japan, Mexico, China, and Canada. The company is actively involved in global welfare initiatives, collaborating with local organizations to enhance animal health and welfare.